At a glance
ClinicalIndex Comparison RecordN/ACompleted· 149 enrolled
Drug / intervention
Carpal Tunnel Release with Ultrasound Guidance using the UltraGuideCTR devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Prospective Trial of Office-based Carpal Tunnel Release With Ultrasound Guidance (ROBUST)
In Brief
A clinical study evaluating Carpal Tunnel Release with Ultrasound Guidance using the UltraGuideCTR device for Carpal Tunnel Syndrome and CTS. Completed, enrolled 149 participants across 7 sites.
Detailed Summary
Multicenter prospective single-arm trial of subjects with symptomatic Carpal Tunnel Syndrome treated with Ultrasound Guided Carpal Tunnel Release (CTR-US) in an office-based setting.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCarpal Tunnel Syndrome, CTS
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJan 2023
Enrollment StartFeb 2023
Primary CompletionSep 2023
Study CompletionAug 2025
TodayJul 2026
First PostedJan 9, 2023
Enrollment StartFeb 16, 2023
Primary CompletionSep 24, 2023
Study CompletionAug 6, 2025
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 3.5 years ago
Interventions
Carpal Tunnel Release with Ultrasound Guidance using the UltraGuideCTR devicedevice
Participants who were treated with the Carpal Tunnel Release with Ultrasound Guidance procedure using the UltraGuideCTR device in the ROBUST Study.